{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:57:55Z","timestamp":1780498675282,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T00:00:00Z","timestamp":1324684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00296-011-2329-5","type":"journal-article","created":{"date-parts":[[2011,12,23]],"date-time":"2011-12-23T05:55:52Z","timestamp":1324619752000},"page":"3897-3901","source":"Crossref","is-referenced-by-count":15,"title":["A comparative study on the diversity of clinical features between the sero-negative and sero-positive rheumatoid arthritis patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Yan","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,24]]},"reference":[{"key":"2329_CR1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/1529-0131(200106)44:6<1248::AID-ART215>3.0.CO;2-8","volume":"44","author":"M Bukhari","year":"2001","unstructured":"Bukhari M et al (2001) Time to first occurrence of erosions in inflammatory polyarthritis: results from a prospective community-based study. Arthr Rheum 44:1248\u20131253","journal-title":"Arthr Rheum"},{"key":"2329_CR2","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","volume":"64","author":"VP Nell","year":"2005","unstructured":"Nell VP et al (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64:1731\u20131736","journal-title":"Ann Rheum Dis"},{"key":"2329_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00541233","volume":"3","author":"J Edelman","year":"1983","unstructured":"Edelman J, Russell AS (1983) A comparison of patients with seropositive and seronegative rheumatoid arthritis. Rheumatol Int 3:47\u201348","journal-title":"Rheumatol Int"},{"key":"2329_CR4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03009740310003677","volume":"32","author":"K Suzuki","year":"2003","unstructured":"Suzuki K et al (2003) High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32:197\u2013204","journal-title":"Scand J Rheumatol"},{"key":"2329_CR5","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH Van der Helm-van Mil","year":"2005","unstructured":"Van der Helm-van Mil AH et al (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthr Res Ther 7:R949\u2013R958","journal-title":"Arthr Res Ther"},{"key":"2329_CR6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","volume":"63","author":"L Rycke De","year":"2004","unstructured":"De Rycke L et al (2004) Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 63:1587\u20131593","journal-title":"Ann Rheum Dis"},{"key":"2329_CR7","first-page":"466","volume":"11","author":"R Chen","year":"2007","unstructured":"Chen R et al (2007) Clinical and laboratory features of rheumatoid arthritis that has negative serum autoantibodies. Chin J Rheumatol 11:466\u2013468","journal-title":"Chin J Rheumatol"},{"key":"2329_CR8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.clinbiochem.2006.06.004","volume":"39","author":"C Korkmaz","year":"2006","unstructured":"Korkmaz C et al (2006) Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations. Clin Biochem 39:961\u2013965","journal-title":"Clin Biochem"},{"key":"2329_CR9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.17305\/bjbms.2010.2729","volume":"10","author":"V Sahatciu-Meka","year":"2010","unstructured":"Sahatciu-Meka V et al (2010) Extra-articular manifestations of seronegative and seropositive rheumatoid arthritis. Bosn J Basic Med Sci 10:26\u201331","journal-title":"Bosn J Basic Med Sci"},{"key":"2329_CR10","first-page":"268","volume":"8","author":"E Ikeda","year":"1998","unstructured":"Ikeda E et al (1998) Rheumatoid vasculitis in a patient with seronegative rheumatoid arthritis. Eur J Dermatol 8:268\u2013270","journal-title":"Eur J Dermatol"},{"key":"2329_CR11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/014107689909201012","volume":"92","author":"CS Carr","year":"1999","unstructured":"Carr CS, Roxburgh JC (1999) Heart valve disease in seronegative rheumatoid arthritis. J R Soc Med 92:531\u2013532","journal-title":"J R Soc Med"},{"key":"2329_CR12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/kel202","volume":"46","author":"T Bongartz","year":"2007","unstructured":"Bongartz T et al (2007) Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 46:70\u201375","journal-title":"Rheumatology (Oxford)"},{"key":"2329_CR13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/ard.51.9.1029","volume":"51","author":"D Zeben van","year":"1992","unstructured":"van Zeben D et al (1992) Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 51:1029\u20131035","journal-title":"Ann Rheum Dis"},{"key":"2329_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1196\/annals.1313.031","volume":"1050","author":"A Greiner","year":"2005","unstructured":"Greiner A et al (2005) Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann NY Acad Sci 1050:295\u2013303","journal-title":"Ann NY Acad Sci"},{"key":"2329_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10067-009-1337-2","volume":"29","author":"H Li","year":"2010","unstructured":"Li H et al (2010) Diagnostic value of anti-cyclic citrullinated peptide antibodies in northern Chinese Han patients with rheumatoid arthritis and its correlation with disease activity. Clin Rheumatol 29:413\u2013417","journal-title":"Clin Rheumatol"},{"key":"2329_CR16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/17402520500233510","volume":"12","author":"O Shovman","year":"2005","unstructured":"Shovman O et al (2005) The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Clin Dev Immunol 12:197\u2013202","journal-title":"Clin Dev Immunol"},{"key":"2329_CR17","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","volume":"45","author":"MA Quinn","year":"2006","unstructured":"Quinn MA et al (2006) Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford) 45:478\u2013480","journal-title":"Rheumatology (Oxford)"},{"key":"2329_CR18","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","volume":"56","author":"H Dongen van","year":"2007","unstructured":"van Dongen H et al (2007) Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthr Rheum 56:1424\u20131432","journal-title":"Arthr Rheum"},{"key":"2329_CR19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3349\/ymj.2005.46.4.464","volume":"46","author":"YS Shin","year":"2005","unstructured":"Shin YS et al (2005) Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. Yonsei Med J 46:464\u2013470","journal-title":"Yonsei Med J"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2329-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2329-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:06:12Z","timestamp":1561104372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2329-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,24]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2329"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2329-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,24]]}}}